The new approach, using engineered sEVs to target DR5, outperformed DR5-targeting antibodies ... vesicles to target DR5 because these nano-sized capsules—about a million times smaller than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback